According to Telo Genomics latest financial reports the cash on hand of TELO is $1.96M, an decrease of -0.66% to 2022. At the end of 2022 company had $1.98M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.96M | -0.66% |
2022 | $1.98M | -26.00% |
2021 | $2.67M | 294.85% |
2020 | $676.47K | 4624.20% |
2019 | $14.32K | - |